Whitefish, Manitoba--(Newsfile Corp. - June 16, 2020) - CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announced the launch of PsyIndex.com, a free premier stock index site and research tool designed for investors, bankers, analysts, journalists and other market participants interested in following and profiting from the emerging multi-billion dollar psychedelics and mushroom industry. The PsyIndex aggregates and tracks the public markets performance of the industry together with associated private companies, breaking news, media coverage and events.
The psychedelics industry could capture a meaningful part of the $28.6 billion global antidepressant market over the coming years as research programs and clinical trials progress towards commercialized treatment solutions. Ketamine, Psilocybin, MDMA and other psychedelics could also play a leading role in treating other high profile medical conditions, including anxiety, post-traumatic stress disorder (PTSD), ADHD and addiction. Newly formed private and public companies focused on the drug development, patient interaction and ancillary segments of the industry have peaked investor interest.
The PsyIndex has several powerful features to help users assess the current and historic status and trends of the psychedelics market while supporting due diligence:
-
Visualize and track the market performance of publicly traded psychedelic companies with a single market capitalization-weighted metric and chart
-
Research and analyze the private and public companies (index constituents) in the space with corporate profiles, fundamental and financial data, live charts and capital markets / financing updates
-
Access breaking industry and company-specific news, announcements and media coverage
-
View an updated calendar of leading industry events and trade shows
-
Receive free email alerts when psychedelics companies announce new financings, mergers/acquisitions, initial public offerings, public listings or other transactions
"The psychedelics industry is one of the top emerging markets for investor interest around the world," said CFN Media President Frank Lane. "Our PsyIndex consolidates the industry's rapidly evolving capital markets activity into a single free dynamic destination to help investors gain an edge."
In partnership with the Canadian Securities Exchange (CSE), join CFN Media's previously announced June 17th Investing in Psychedelics conference that will bring together the psychedelics industry's preeminent public and private company executives and thought leaders to discuss investment opportunities.
Public and private companies involved in the psychedelics space that would like to be included in the index can visit https://www.psyindex.com.
CFN Media has helped hundreds of companies in emerging highly regulated industries attract investors, capital and media attention at scale across its powerful digital content and media network. Learn more at: https://www.cannabisfn.com/become-featured-company/.
About CFN Enterprises Inc.
CFN Enterprises Inc. (OTCQB: CNFN) is a digital media and e-commerce company focused on advancing businesses and brands in highly regulated emerging industries across the globe. CFN connects investors with new market opportunities while helping consumers find innovative products that enhance their lives. Learn more at www.cfnenterprisesinc.com.
CFN Enterprises Inc. Media Contact:
CFN Enterprises Inc.
+001 (833) 420-CNFN
investors@cfnenterprisesinc.com
FORWARD-LOOKING STATEMENT
Use of Forward-looking Statements
This press release may contain forward-looking statements from CFN Enterprises Inc. within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995 and federal securities laws. For example, when CFN Enterprises Inc. describes the potential acquisition of BarNone assets and the related benefits, its pursuit of M&A opportunities, growth in CBD sales and spending on affiliate marketing, and uses other statements containing the words "believes," "anticipates," "plans," "expects," "will" and similar expressions, CFN Enterprises Inc. is using forward-looking statements. These forward-looking statements are based on the current expectations of the management of CFN Enterprises Inc. only, and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. The following factors, among others, could cause actual results to differ materially from those described in the forward-looking statements: regulatory and licensing risks; changes in general economic, business and political conditions, including changes in the financial markets; the regulatory landscape and enforcement related to cannabis, including political risks and risks relating to regulatory change; changes in applicable laws; compliance with extensive government regulation; public opinion and perception of the cannabis industry; we may be unable to retain or attract key employees whose knowledge is essential to the development of our products and services; or, loss of market share and pressure on pricing resulting from competition, which could cause the actual results or performance of CFN Enterprises Inc. to differ materially from those contemplated in such forward-looking statements. Except as otherwise required by law, CFN Enterprises Inc. undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. For a more detailed description of the risk and uncertainties affecting CFN Enterprises Inc., reference is made to CFN Enterprises Inc.'s reports filed from time to time with the Securities and Exchange Commission.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/57944
copyright (c) newsfile corp. 2020